15876830

Source:http://linkedlifedata.com/resource/pubmed/id/15876830

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0175668, umls-concept:C0936012, umls-concept:C1524112, umls-concept:C2603343
pubmed:dateCreated	2005-5-6
pubmed:abstractText	The HEMO Study was a randomized clinical trial designed to determine whether increasing hemodialysis dose above current standards, or using high-flux membranes, would improve patient outcome. The primary results of the trial showed no statistically significant effects of either dialysis dose or membrane flux on the primary outcome of mortality.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7513582
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Membranes, Artificial
pubmed:status	MEDLINE
pubmed:issn	0302-5144
pubmed:author	pubmed-author:GreeneTomT
pubmed:issnType	Print
pubmed:volume	149
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	69-82
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15876830-Body Size, pubmed-meshheading:15876830-Equipment Design, pubmed-meshheading:15876830-Humans, pubmed-meshheading:15876830-Membranes, Artificial, pubmed-meshheading:15876830-Randomized Controlled Trials as Topic, pubmed-meshheading:15876830-Renal Dialysis, pubmed-meshheading:15876830-Research Design, pubmed-meshheading:15876830-Sex Factors, pubmed-meshheading:15876830-Time Factors, pubmed-meshheading:15876830-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	What did we learn from the HEMO Study? Implications of secondary analyses.
pubmed:affiliation	Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. tgreene@bio.ri.ccf.org
pubmed:publicationType	Journal Article, Review